Identification of immunogenic determinants of the spike protein of SARS-like coronavirus

Virologica Sinica

Volumn 28, Issue 2, 2013, Pages 92-96

  Zhou, Peng ^a,b   Han, Zhenggang ^a   Wang, Lin Fa ^b,c   Shi, Zhengli ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b CSIRO   (Australia)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Bat; Immune; SL CoV; Vaccine

Indexed keywords

MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; VIRUS SPIKE PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNE RESPONSE; IMMUNOGENICITY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; RNA SEQUENCE; SARS CORONAVIRUS; SEQUENCE ANALYSIS; VIRUS IDENTIFICATION; WESTERN BLOTTING;

ADENOVIRIDAE; HUMANS; MOLECULAR EPIDEMIOLOGY; SARS VIRUS; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

EID: 84884517928     PISSN: 16740769     EISSN: 1995820X     Source Type: Journal    
DOI: 10.1007/s12250-013-3292-y     Document Type: Article

References (16)

1. Becker M M, Graham R L, Donaldson E F, Rockx B, Sims A C, Sheahan T, Pickles R J, Corti D, Johnston R E, Baric R S, and Denison M R. 2008. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc Natl Acad Sci USA, 105:19944-19949.
2. Evan G I, Lewis G K, Ramsay G, and Bishop J M. 1985. Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product. Mol Cell Biol, 5:3610-3616.
3. He Y. 2006. Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies. Adv Exp Med Biol, 581:539-542.
4. He Y, Zhou Y, Wu H, Luo B, Chen J, Li W, and Jiang S. 2004. Identification of immunodominant sites on the spike protein of severe acute respiratory syndrome (SARS) coronavirus: implication for developing SARS diagnostics and vaccines. J Immunol, 173:4050-4057.
5. He Y, Zhou Y, Liu S, Kou Z, Li W, Farzan M, and Jiang S. 2004. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem Biophys Res Commun, 324:773-781.
6. Hua R, Zhou Y, Wang Y, Hua Y, and Tong G 2004. Identification of two antigenic epitopes on SARS-CoV spike protein. Biochem Biophys Res Commun, 319:929-935.
7. Lau S K, Woo P C, Li K S, Huang Y, Tsoi H W, Wong B H, Wong S S, Leung S Y, Chan K H, and Yuen K Y. 2005. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc Natl Acad Sci USA, 102:14040-14045.
8. Lau S K, Li K S, Huang Y, Shek C T, Tse H, Wang M, Choi G K, Xu H, Lam C S, Guo R, Chan K H, Zheng B J, Woo P C, and Yuen K Y. 2010. Ecoepidemiology and complete genome comparison of different strains of severe acute respiratory syndrome-related Rhinolophus bat coronavirus in China reveal bats as a reservoir for acute, self-limiting infection that allows recombination events. J Virol, 84:2808-2819.
9. Li W, Shi Z, Yu M, Ren W, Smith C, Epstein J H, Wang H, Crameri G, Hu Z, Zhang H, Zhang J, McEachem J, Field H, Daszak P, Eaton B T, Zhang S, and Wang L F. 2005. Bats are natural reservoirs of SARS-like coronaviruses. Science, 310:676-679.
10. Ren W, Qu X, Li W, Han Z, Yu M, Zhou P, Zhang S Y, Wang L F, Deng H, and Shi Z. 2008. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J Virol, 82:1899-1907.
11. Ren W, Li W, Yu M, Hao P, Zhang Y, Zhou P, Zhang S, Zhao G, Zhong Y, Wang S, Wang L F, and Shi Z. 2006. Full-length genome sequences of two SARS-like coronaviruses in horseshoe bats and genetic variation analysis. J Gen Virol, 87:3355-3359.
12. Tang X C, Zhang J X, Zhang S Y, Wang P, Fan X H, Li L F, Li G, Dong B Q, Liu W, Cheung C L, Xu K M, Song W J, Vijaykrishna D, Poon L L, Peiris J S, Smith G J, Chen H, and Guan Y. 2006. Prevalence and genetic diversity of coronaviruses in bats from China. J Virol, 80:7481-7490.
13. Wilson C M. 1983. Staining of proteins on gels: comparisons of dyes and procedures. Methods Enzymol, 91:236-247.
14. Yuan J, Hon C C, Li Y, Wang D, Xu G, Zhang H, Zhou P, Poon L L, Lam T T, Leung F C, and Shi Z. 2010. Intraspecies diversity of SARS-like coronaviruses in Rhinolophus sinicus and its implications for the origin of SARS coronaviruses in humans. J Gen Virol, 91:1058-1062.
15. Zhou P, Han Z, Wang L F, and Shi Z. 2009. Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins. Biochem Biophys Res Commun, 387:326-329.
16. Zhu Z, Chakraborti S, He Y, Roberts A, Sheahan T, Xiao X, Hensley L E, Prabakaran P, Rockx B, Sidorov I A, Corti D, Vogel L, Feng Y, Kim J O, Wang L F, Baric R, Lanzavecchia A, Curtis K M, Nabel G J, Subbarao K, Jiang S, and Dimitrov D S. 2007. Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies. Proc Natl Acad Sci US A, 104:12123-12128.